Population Pharmacokinetics of Levetiracetam in Patients with Traumatic Brain Injury and Subarachnoid Hemorrhage Exhibiting Augmented Renal Clearance

Fekade Bruck Sime,Jason A. Roberts,Rosalind L. Jeffree,Saurabh Pandey,Santosh Adiraju,Amelia Livermore,Jenie Butler,Suzanne L. Parker,Steven C. Wallis,Jeffrey Lipman,Menino Osbert Cotta
DOI: https://doi.org/10.1007/s40262-020-00979-8
2021-01-11
Clinical Pharmacokinetics
Abstract:Patients with severe trauma exhibit augmented renal clearance, which can alter the dosing requirement of renally eliminated drugs. This study aimed to develop a population pharmacokinetic model for levetiracetam in patients with severe traumatic brain injury and aneurysmal subarachnoid hemorrhage, and use it to describe optimal dosing regimens.
pharmacology & pharmacy
What problem does this paper attempt to address?